Related Experiment Video
Updated: May 25, 2025
07:51
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.5K
Treating Cardiovascular Disorders with Personalized Medicine.
Ishu Garg1, Harish Kumar1, Madhu Verma2
1Sardar Bhagwan Singh Post Graduate Institute of Biomedical Sciences and Research, Balawala, Dehradun, Uttarakhand, 248161, India.
Cardiovascular & Hematological Disorders Drug Targets
|February 27, 2025
Summary
Personalized cardiology tailors cardiovascular treatments using genomics and molecular diagnostics. This approach aims to improve diagnosis, prevention, and therapy for heart conditions by understanding individual patient pathology.
Area of Science:
- Cardiovascular medicine
- Genomics
- Proteomics
Background:
- Personalized medicine offers tailored treatments for individual patients.
- Personalized cardiology is an emerging field for cardiovascular disorders, integrating genomics and proteomics.
- Molecular diagnostics and biomarkers are crucial for linking diagnosis with therapy in cardiovascular disease.
Purpose of the Study:
- To review parameters for personalizing cardiovascular disorder treatment.
- To highlight the role of molecular genetics in advancing personalized cardiology.
- To discuss the potential of personalized approaches in diagnosing, preventing, and treating cardiovascular conditions.
Main Methods:
- Genomics and proteomics analysis.
- Biomarker identification and utilization.
- Bioinformatics for risk stratification.
- Integration of 3D printing, pharmacotherapy, surgery, and lifestyle modifications.
Main Results:
- Personalized cardiology enables tailored diagnosis and therapy for cardiovascular disorders.
- Understanding individual pathology and genetic factors is key to developing targeted treatments.
- Bioinformatics can enhance cardiovascular disease risk prediction algorithms.
Conclusions:
- Personalized cardiology holds significant promise for managing cardiovascular disorders.
- Overcoming scientific and policy obstacles is essential for clinical implementation.
- Improved disease classification and understanding of individual differences will drive targeted therapies.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:23Assessment of the Cardiovascular System I: Subjective Data
261
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
261
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
126
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
126
01:29Pathophysiology of Cardiac Performance
509
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
509
01:17Increased pulse rate
635
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
635